FITB
60
-5
SEE
53
3
ESS
62
-3
KIM
72
2
EA
60
-5
DHR
32
-6
CI
45
-3
SRE
63
2
O
17
-13
PPG
57
-3
RSG
65
-3
RIG
43
-7
HCA
48
-2
EQR
54
3
HPE
44
-2
EW
32
3
CA
22
-3
CINF
53
3
TEL
60
-8
TROW
47
-6
FITB
60
-5
SEE
53
3
ESS
62
-3
KIM
72
2
EA
60
-5
DHR
32
-6
CI
45
-3
SRE
63
2
O
17
-13
PPG
57
-3
RSG
65
-3
RIG
43
-7
HCA
48
-2
EQR
54
3
HPE
44
-2
EW
32
3
CA
22
-3
CINF
53
3
TEL
60
-8
TROW
47
-6
Financhill
Back

Verona Pharma PLC Stock Predictions

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Sell
37

VRNA
Verona Pharma PLC

Last Price:
35.65
Seasonality Move:
20.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Verona Pharma PLC Stock Forecast

  • Over the next 52 weeks, Verona Pharma PLC has on average historically risen by 41.9% based on the past 7 years of stock performance.
  • Verona Pharma PLC has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is Verona Pharma PLC Stock Undervalued?
    The current Verona Pharma PLC [VRNA] share price is $35.66. The Score for VRNA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • VRNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Verona Pharma PLC Stock Go Up Next Year?

  • Over the next 52 weeks, Verona Pharma PLC has on average historically risen by 41.9% based on the past 7 years of stock performance.

Verona Pharma PLC Stock Rating

Sell
37
Verona Pharma PLC (VRNA) is a Sell

Is Verona Pharma PLC overpriced?

  • Verona Pharma PLC has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Verona Pharma PLC Stock Price History

Is VRNA stock going to rise?

  • The current trend is moderately bearish and VRNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
veronapharma.com

52-Week Data

52-Week High:
40.13
52-Week Low:
11.39

Prediction Charts

Market Cap:
2.92B
Price in USD:
35.66
Volume:
985.39K
Beta:
0.16

Technical Analysis

SMA50:
32.61
SMA100:
27.58
SMA200:
21.51
52-Wk Change:
148.5%

Stock Predictions

  • Is Verona Pharma PLC stock public?
    Yes, Verona Pharma PLC is a publicly traded company.
  • What is the Verona Pharma PLC stock quote today?
    The Verona Pharma PLC stock price is 35.66 USD today.
  • How to buy Verona Pharma PLC stock online?
    You can buy Verona Pharma PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 33.02 33.66 33.87 32.90
Oct-30 33.09 34.16 34.77 33.09
Oct-31 34.00 33.93 34.33 33.31
Nov-1 34.42 34.98 35.09 34.01
Nov-4 33.55 38.18 39.38 31.60
Nov-5 39.05 38.39 39.40 37.80
Nov-6 38.39 37.59 38.56 36.74
Nov-7 37.54 38.18 38.25 36.49
Nov-8 38.50 38.58 38.87 37.52
Nov-11 38.97 39.86 40.03 38.73
Nov-12 39.35 39.00 40.13 38.78
Nov-13 39.00 36.94 39.50 36.84
Nov-14 37.49 35.37 37.49 34.95
Nov-15 35.01 35.66 35.97 34.71

Verona Pharma PLC Earnings

Verona Pharma PLC Earnings Report: Per Share Verona Pharma PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.

Verona Pharma PLC Forecast Revenue Growth

Verona Pharma PLC Stock Analysis: Historical quarterly revenues per share for Verona Pharma PLC and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.40 per share.

* Verona Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.